As long as we’re walking off a cliff, it might as well be a big one!
This morning, the New York Times
published an article
that noted a quiet announcement made by the Trump administration on a website recently:
The Biomedical Advanced Research and Development Authority, or BARDA, is no
longer going to fund development of new treatments for severe lung damage
caused by Covid-19; instead, they’re going to put even more of their eggs in
the basket of vaccine development.
Of course, serious cases of Covid-19
usually include a devastating attack on the lungs, leaving patients unable to
breathe without a ventilator. Even when they survive this experience, patients
often experience lung damage as a result. A medical professional is quoted in
the article as saying “The majority of patients who are in hospitals are dying
because of lung injury.”
Meanwhile, we’re already investing a
huge amount of money in vaccine research, to try to reach Trump’s goal of
having a vaccine ready and in distribution by the end of the year - even if this
means cutting some corners and ending up with a vaccine that doesn’t work well
or is literally harmful. The article says that “BARDA has pledged more than
$2.2 billion in deals with five vaccine manufacturers for the coronavirus,
compared with about $359 million toward potential Covid-19 treatments.” Hmm,
can you imagine why the administration would be so focused on having the
vaccine this year, even though this might lead to our being further behind on a
vaccine next year, if whatever bets they make this year don’t work out? For the
life of me, I can’t think of a single reason…
Of course, the sensible thing would be
to pursue both goals at the same time! After all, $359 million isn’t that huge
a number compared to other initiatives. For example, the government currently has
61 million doses of hydroxychloroquine on hand (which have to be worth more
than $359 million), since it turns out that the “science” that led Trump to
believe this was the solution to Covid-19 wasn’t quite so solid after all – and
now it turns out the drug can literally cause heart problems and death in Covid-19
patients. Who would have thought?
And in case you’re wondering, BARDA is
the agency that Rick Bright headed, who was reassigned because he wouldn’t go
along with efforts to fund hydroxychloroquine. Obviously, his successor isn’t
quite so squeamish about bowing to political pressure.
The moral of the story: If you’re sick
now or might get sick sometime in the future, you’d better pray that the risky bet
on an accelerated vaccine pays off, since the Trump administration has decided that
trying to save patients who get sick before a vaccine is available is Job
Number Two (if that), not Job Number One.
The
numbers
These
numbers are updated every day, based on reported US Covid-19 deaths the day
before (taken from the Worldometers.info site, where I’ve been getting my
numbers all along). No other variables go into the projected numbers – they are
all projections based on yesterday’s 7-day rate of increase in total Covid-19
deaths, which was 4%.
Note
that the “accuracy” of the projected numbers diminishes greatly after 3-4
weeks. This is because, up until 3-4 weeks, deaths could in theory be predicted
very accurately, if one knew the real number of cases. In other words, the
people who are going to die in the next 3-4 weeks of Covid-19 are already sick
with the disease, even though they may not know it yet. But this means that the
trend in deaths should be some indicator of the level of infection 3-4 weeks
previous.
However,
once we get beyond 3-4 weeks, deaths become more and more dependent on policies
and practices that are put in place – or removed, as is more the case nowadays
- after today (as well as other factors like the widespread availability of an
effective treatment, if not a real “cure”). Yet I still think there’s value in
just trending out the current rate of increase in deaths, since it gives some
indication of what will happen in the near term if there are no significant
intervening changes.
Week ending
|
Deaths reported during week/month
|
Avg. deaths per day during
week/month
|
Deaths as percentage of previous month’s
|
March 7
|
18
|
3
|
|
March 14
|
38
|
5
|
|
March 21
|
244
|
35
|
|
March 28
|
1,928
|
275
|
|
Month of March
|
4,058
|
131
|
|
April 4
|
6,225
|
889
|
|
April 11
|
12,126
|
1,732
|
|
April 18
|
18,434
|
2,633
|
|
April 25
|
15,251
|
2,179
|
|
Month of April
|
59,812
|
1,994
|
1,474%
|
May 2
|
13,183
|
1,883
|
|
May 9
|
12,592
|
1,799
|
|
May 16
|
10,073
|
1,439
|
|
May 23
|
8,570
|
1,224
|
|
May 30
|
6,874
|
982
|
|
Month of May
|
42,327
|
1,365
|
71%
|
June 6
|
6,544
|
935
|
|
June 13
|
5,427
|
775
|
|
June 20
|
4,695
|
671
|
|
June 27
|
4,883
|
698
|
|
Month of June
|
22,656
|
755
|
55%
|
July 4
|
5,078
|
725
|
|
July 11
|
5,280
|
754
|
|
July 18
|
5,491
|
784
|
|
July 25
|
5,711
|
816
|
|
Month of July
|
24,854
|
802
|
110%
|
Total March – July
|
153,707
|
|
|
Red = projected numbers
I. Total
deaths
Total US deaths as of yesterday: 120,688
Increase in deaths since previous day: 745
Yesterday’s 7-day rate of increase in total deaths: 4% (This number
is used to project deaths in the table above; it was 4% yesterday. There is a
7-day cycle in the reported deaths numbers, caused by lack of reporting over
the weekends from closed state offices. So this is the only reliable indicator
of a trend in deaths, not the three-day percent increase I used to focus on,
and certainly not the one-day percent increase, which mainly reflects where we
are in the 7-day cycle).
II. Total
reported cases
Total US reported cases: 2,263,982
Increase in reported cases since previous day: 29,128
Percent increase in reported cases since yesterday: 1%
Percent increase in reported cases since 7 days previous: 8%
III. Deaths as a percentage of closed cases so far
in the US:
Total Recoveries in US as of yesterday: 931,079
Total Deaths as of yesterday: 120,688
Deaths so far as percentage of closed cases (=deaths + recoveries): 11%
(vs. 12% yesterday)
I would love to hear any comments or
questions you have on this post. Drop me an email at tom@tomalrich.com
Comments
Post a Comment